The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study
Background and Aims. Screening for gastric diseases in symptomatic outpatients with conventional esophagogastroduodenoscopy (C-EGD) is expensive and has poor compliance. We aimed to explore the efficiency and safety of magnetic-controlled capsule gastroscopy (MCCG) in symptomatic outpatients who ref...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2021/6934594 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832561393635688448 |
---|---|
author | Lihan Zhou Sijia Wang Jian Li Jie Zhong Ling Zhang Ruizhe Shen Bielike Kouken Chunhua Zhou Qi Wang Yuting Qian Duowu Zou Ye Chu |
author_facet | Lihan Zhou Sijia Wang Jian Li Jie Zhong Ling Zhang Ruizhe Shen Bielike Kouken Chunhua Zhou Qi Wang Yuting Qian Duowu Zou Ye Chu |
author_sort | Lihan Zhou |
collection | DOAJ |
description | Background and Aims. Screening for gastric diseases in symptomatic outpatients with conventional esophagogastroduodenoscopy (C-EGD) is expensive and has poor compliance. We aimed to explore the efficiency and safety of magnetic-controlled capsule gastroscopy (MCCG) in symptomatic outpatients who refused C-EGD. Methods. We performed a retrospective study of 76794 consecutive symptomatic outpatients from January 2014 to October 2019. A total of 2318 adults (F/M=1064/1254) in the MCCG group who refused C-EGD were matched with adults in the C-EGD group using propensity-score matching (PSM). The detection rates of abnormalities were analyzed to explore the application of MCCG in symptomatic patients. Results. Our study demonstrated a prevalence of gastric ulcers (GUs) in patients with functional dyspepsia- (FD-) like symptoms of 8.14%. The detection rate of esophagitis and Barrett’s esophagus was higher in patients with typical gastroesophageal reflux disease (GERD) symptoms than in patients in the other four groups (P<0.01). The detection rates of gastric ulcers in the five groups (abdominal pain, bloating, heartburn, follow-up, and bleeding) were significantly different (P=0.015). The total detection rate of gastric ulcers in symptomatic patients was 9.7%. A total of 7 advanced carcinomas were detected by MCCG and confirmed by endoscopic or surgical biopsy. The advanced gastric cancer detection rate was not significantly different between the MCCG group and the C-EGD matched group in terms of nonhematemesis GI bleeding (2 vs. 2, P=1.00). In addition, the overall focal lesion detection rate in the MCCG group was superior to that in the C-EGD matched group (224 vs. 184, P=0.038). MCCG gained a clinically meaningful small bowel diagnostic yield of 54.8% (17/31) out of 31 cases of suspected small bowel bleeding. No patient reported capsule retention at the two-week follow-up. Conclusion. MCCG is well tolerated, safe, and technically feasible and has a considerable diagnostic yield. The overall gastric diagnostic yield of gastric focal lesions with MCCG was comparable to that with C-EGD. MCCG offered a supplementary diagnosis in patients who had a previously undiagnostic C-EGD, indicating that MCCG could play an important role in the routine monitoring and follow-up of outpatient. MCCG shows its safety and efficiency in symptomatic outpatient applications. |
format | Article |
id | doaj-art-e8cdffc1d9124e998b2cc440b8cd0bdd |
institution | Kabale University |
issn | 1687-6121 1687-630X |
language | English |
publishDate | 2021-01-01 |
publisher | Wiley |
record_format | Article |
series | Gastroenterology Research and Practice |
spelling | doaj-art-e8cdffc1d9124e998b2cc440b8cd0bdd2025-02-03T01:25:18ZengWileyGastroenterology Research and Practice1687-61211687-630X2021-01-01202110.1155/2021/69345946934594The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational StudyLihan Zhou0Sijia Wang1Jian Li2Jie Zhong3Ling Zhang4Ruizhe Shen5Bielike Kouken6Chunhua Zhou7Qi Wang8Yuting Qian9Duowu Zou10Ye Chu11Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaClinical Research Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaBackground and Aims. Screening for gastric diseases in symptomatic outpatients with conventional esophagogastroduodenoscopy (C-EGD) is expensive and has poor compliance. We aimed to explore the efficiency and safety of magnetic-controlled capsule gastroscopy (MCCG) in symptomatic outpatients who refused C-EGD. Methods. We performed a retrospective study of 76794 consecutive symptomatic outpatients from January 2014 to October 2019. A total of 2318 adults (F/M=1064/1254) in the MCCG group who refused C-EGD were matched with adults in the C-EGD group using propensity-score matching (PSM). The detection rates of abnormalities were analyzed to explore the application of MCCG in symptomatic patients. Results. Our study demonstrated a prevalence of gastric ulcers (GUs) in patients with functional dyspepsia- (FD-) like symptoms of 8.14%. The detection rate of esophagitis and Barrett’s esophagus was higher in patients with typical gastroesophageal reflux disease (GERD) symptoms than in patients in the other four groups (P<0.01). The detection rates of gastric ulcers in the five groups (abdominal pain, bloating, heartburn, follow-up, and bleeding) were significantly different (P=0.015). The total detection rate of gastric ulcers in symptomatic patients was 9.7%. A total of 7 advanced carcinomas were detected by MCCG and confirmed by endoscopic or surgical biopsy. The advanced gastric cancer detection rate was not significantly different between the MCCG group and the C-EGD matched group in terms of nonhematemesis GI bleeding (2 vs. 2, P=1.00). In addition, the overall focal lesion detection rate in the MCCG group was superior to that in the C-EGD matched group (224 vs. 184, P=0.038). MCCG gained a clinically meaningful small bowel diagnostic yield of 54.8% (17/31) out of 31 cases of suspected small bowel bleeding. No patient reported capsule retention at the two-week follow-up. Conclusion. MCCG is well tolerated, safe, and technically feasible and has a considerable diagnostic yield. The overall gastric diagnostic yield of gastric focal lesions with MCCG was comparable to that with C-EGD. MCCG offered a supplementary diagnosis in patients who had a previously undiagnostic C-EGD, indicating that MCCG could play an important role in the routine monitoring and follow-up of outpatient. MCCG shows its safety and efficiency in symptomatic outpatient applications.http://dx.doi.org/10.1155/2021/6934594 |
spellingShingle | Lihan Zhou Sijia Wang Jian Li Jie Zhong Ling Zhang Ruizhe Shen Bielike Kouken Chunhua Zhou Qi Wang Yuting Qian Duowu Zou Ye Chu The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study Gastroenterology Research and Practice |
title | The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study |
title_full | The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study |
title_fullStr | The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study |
title_full_unstemmed | The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study |
title_short | The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study |
title_sort | application of magnetic controlled capsule gastroscopy in patients refusing c egd a single center 5 year observational study |
url | http://dx.doi.org/10.1155/2021/6934594 |
work_keys_str_mv | AT lihanzhou theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT sijiawang theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT jianli theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT jiezhong theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT lingzhang theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT ruizheshen theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT bielikekouken theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT chunhuazhou theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT qiwang theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT yutingqian theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT duowuzou theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT yechu theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT lihanzhou applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT sijiawang applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT jianli applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT jiezhong applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT lingzhang applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT ruizheshen applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT bielikekouken applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT chunhuazhou applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT qiwang applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT yutingqian applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT duowuzou applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy AT yechu applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy |